90 related articles for article (PubMed ID: 31261158)
1. Comprehensive HIV risk reduction interventions for 2020 and beyond: product choices and effective service-delivery platforms for individual needs and population-level impact.
Velloza J; Delany-Moretlwe S; Baeten JM
Curr Opin HIV AIDS; 2019 Sep; 14(5):423-432. PubMed ID: 31261158
[TBL] [Abstract][Full Text] [Related]
2. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
[TBL] [Abstract][Full Text] [Related]
3. How home HIV testing and counselling with follow-up support achieves high testing coverage and linkage to treatment and prevention: a qualitative analysis from Uganda.
Ware NC; Wyatt MA; Asiimwe S; Turyamureeba B; Tumwesigye E; van Rooyen H; Barnabas RV; Celum CL
J Int AIDS Soc; 2016; 19(1):20929. PubMed ID: 27357495
[TBL] [Abstract][Full Text] [Related]
4. Opportunities and Challenges of Digital Technology for HIV Treatment and Prevention.
Simoni JM; Kutner BA; Horvath KJ
Curr HIV/AIDS Rep; 2015 Dec; 12(4):437-40. PubMed ID: 26412082
[TBL] [Abstract][Full Text] [Related]
5. Population-level impact of an accelerated HIV response plan to reach the UNAIDS 90-90-90 target in Côte d'Ivoire: Insights from mathematical modeling.
Maheu-Giroux M; Vesga JF; Diabaté S; Alary M; Baral S; Diouf D; Abo K; Boily MC
PLoS Med; 2017 Jun; 14(6):e1002321. PubMed ID: 28617810
[TBL] [Abstract][Full Text] [Related]
6. Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects.
Chang LW; Serwadda D; Quinn TC; Wawer MJ; Gray RH; Reynolds SJ
Lancet Infect Dis; 2013 Jan; 13(1):65-76. PubMed ID: 23257232
[TBL] [Abstract][Full Text] [Related]
7. Reaching the second 90: the strategies for linkage to care and antiretroviral therapy initiation.
Bunda BA; Bassett IV
Curr Opin HIV AIDS; 2019 Nov; 14(6):494-502. PubMed ID: 31408009
[TBL] [Abstract][Full Text] [Related]
8. PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa.
McGillen JB; Anderson SJ; Hallett TB
J Int AIDS Soc; 2016; 19(7(Suppl 6)):21104. PubMed ID: 27760682
[TBL] [Abstract][Full Text] [Related]
9. Efficiency of HIV services in Nigeria: Determinants of unit cost variation of HIV counseling and testing and prevention of mother-to-child transmission interventions.
Bautista-Arredondo S; La Hera-Fuentes G; Contreras-Loya D; Kwan A; Van Buren SJ; Amanze OO; Atobatele A; Adeyemi A; Abatta E; Ogungbemi KM; Sosa-Rubí SG
PLoS One; 2018; 13(9):e0201706. PubMed ID: 30192765
[TBL] [Abstract][Full Text] [Related]
10. A world of choices: preference elicitation methods for improving the delivery and uptake of HIV prevention and treatment.
Kerkhoff AD; Muiruri C; Geng EH; Hickey MD
Curr Opin HIV AIDS; 2023 Jan; 18(1):32-45. PubMed ID: 36409315
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral Medications for the Prevention of HIV Infection: A Clinical Approach to Preexposure Prophylaxis, Postexposure Prophylaxis, and Treatment as Prevention.
Heendeniya A; Bogoch II
Infect Dis Clin North Am; 2019 Sep; 33(3):629-646. PubMed ID: 31239092
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention.
Reidy M; Gardiner E; Pretorius C; Glaubius R; Torjesen K; Kripke K
PLoS One; 2019; 14(6):e0218710. PubMed ID: 31242240
[TBL] [Abstract][Full Text] [Related]
13. Scaling Up Early Infant Male Circumcision: Lessons From the Kingdom of Swaziland.
Fitzgerald L; Benzerga W; Mirira M; Adamu T; Shissler T; Bitchong R; Malaza M; Mamba M; Mangara P; Curran K; Khumalo T; Mlambo P; Njeuhmeli E; Maziya V
Glob Health Sci Pract; 2016 Jul; 4 Suppl 1(Suppl 1):S76-86. PubMed ID: 27413086
[TBL] [Abstract][Full Text] [Related]
14. Recent efforts in biomedical prevention of HIV.
Landovitz RJ
Top HIV Med; 2007; 15(3):99-103. PubMed ID: 17598929
[TBL] [Abstract][Full Text] [Related]
15. Offering pre-exposure prophylaxis for HIV prevention to pregnant and postpartum women: a clinical approach.
Seidman DL; Weber S; Cohan D
J Int AIDS Soc; 2017 Mar; 20(Suppl 1):21295. PubMed ID: 28361503
[TBL] [Abstract][Full Text] [Related]
16. Eliminating mother to child transmission of HIV-1 and keeping mothers alive: recent progress.
Govender T; Coovadia H
J Infect; 2014 Jan; 68 Suppl 1():S57-62. PubMed ID: 24139190
[TBL] [Abstract][Full Text] [Related]
17. The 'third wave' of HIV prevention: filling gaps in integrated interventions, knowledge, and funding.
Sepúlveda J
Health Aff (Millwood); 2012 Jul; 31(7):1545-52. PubMed ID: 22778344
[TBL] [Abstract][Full Text] [Related]
18. Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptake.
Govender EM; Mansoor LE; Abdool Karim Q
AIDS Care; 2017 Jun; 29(6):734-740. PubMed ID: 27799005
[TBL] [Abstract][Full Text] [Related]
19. HIV research in South Africa: Advancing life.
Gray G; Doherty T; Mohapi L; Coetzee J; Hopkins KL; Malahleha M; Lazarus E; Dietrich J; Pillay-van Wyk V; Laher F
S Afr Med J; 2019 Dec; 109(11b):36-40. PubMed ID: 32252866
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
